Come join us for an insightful discussion on endometriosis.

The virtual panel will feature respected experts in the field:

Dr. Katherine Burns, Associate Professor at the University of Cincinnati, focuses on the phases of endometriosis and its environmental interactions.
Dr. Dan Martin, the Scientific and Medical Director of the Endometriosis Foundation of America, is renowned for his extensive research and clinical expertise on endometriosis.
Dr. Laura Payne, Clinical Psychologist and Assistant Professor at Harvard Medical School, specializes in the neurobiological and psychological dimensions of menstrual pain.

💡 Our discussions will center around three important themes:
·  Improving Endometriosis Detection and Diagnosis
·  Novel Approaches to Pain/Symptom Management
·  Patient Advocacy

RSVP here.

Registration for this event has closed.

About Bethany Corbin

Bethany is the Managing Partner of Women’s Health Innovation Consulting and the Co-Founder of FemInnovation. She is a recognized thought leader at the intersection of women’s health, law, and technology, and was named a Top 200 Trailblazing Leader in Women’s Health and Femtech. Her strategic insights have been featured in top news outlets, including Forbes, Fortune, Bustle, BBC, NPR, and Cosmopolitan, and she is a guest contributor to Entrepreneur and MedCity News. 

About the Session

The femtech industry is experiencing unprecedented growth, with over 2,000 companies and $21.8 billion in funding. Anticipated to revolutionize women’s health through empowerment, personalized insights, and tailored data, femtech is pushing back against traditional medical practices that prioritize the male body. This presentation explores the foundations of femtech, discusses how to build and commercialize femtech products, highlights legal and regulatory frameworks that founders must navigate, and emphasizes the need for collaboration between femtech founders and clinicians/scientists.  

Registration for this event has closed.

About Deena Shakir

Deena's investments span stages and sectors, and include women's health, digital health infrastructure, health equity, foodtech, and fintech. Above all, she seeks out extraordinary, often underdog, founders on a mission.

Prior to Lux, Deena was a Partner at GV (formerly Google Ventures), led product partnerships at Google for health, search, and AI/ML, and directed social impact investments at Google.org. Deena also served as a Presidential Management Fellow at The U.S. Department of State under Secretary Clinton, where she helped launch President Obama’s first Global Entrepreneurship Summit.

Deena self-funded her undergraduate degree at Harvard (Social Studies and Near Eastern Languages & Civilizations) and MA at Georgetown through a variety of merit scholarships and side hustles, including co-founding and selling her first company while in college. She is a Lecturer in Management at the Stanford Graduate School of Business, a Board Director for the National Venture Capital Association, and a member of Kauffman Fellows, Aspen Finance Fellows, and The Council on Foreign Relations.

Deena is a frequent speaker and commentator and has been featured in print and television on Bloomberg, CNBC and NBC, in print in the Wall Street Journal, Fortune, Forbes, Techcrunch, Marie Claire, STAT, and more, and has delivered keynote addresses at major industry conferences. She was named a "Top 30 Under 40 in Healthcare" by Business Insider and "Top Senior Woman to Watch in Venture Capital" by the Wall Street Journal in 2021, "Top 50 in Digital Health" by Rock Health and 40 Under 40 by Fortune Magazine in 2022.

Registration for this event has closed.

About Claire Coder

Claire Coder (Forbes 30under30) is a 25-year-old Thiel Fellow and founder and CEO of Aunt Flow. On a mission to make the world better for people with periods, Aunt Flow stocks public bathrooms with freely accessible tampons and pads. Through Claire’s leadership, Aunt Flow launched patented tampon & pad dispensers in 27k+ bathrooms and raised $17m+ in venture capital.

Coder launched her first company at age 16, designed a bag for Vera Bradley that sold out in 24 hours, and has her own line of GIFs. After getting her period in public without the supplies she needed, at 18-years-old, Claire dedicated her life to developing a solution to ensure businesses and schools can sustainably provide quality period products for free in public bathrooms. 

Since 2016, Aunt Flow has worked with thousands of businesses and schools across North America, including organizations like Google, Princeton University, Netflix, the Phoenix Mercury and more, to offer freely accessible period product dispensers, filled with organic cotton tampons and pads. 

For every 10 period products sold, Aunt Flow donates 1 to non-profits. In 2022, Aunt Flow donated over 1.6 MILLION products to menstruators in need.

As a passionate activist, Claire believes that education on periods and normalizing periods is crucial. She strives to educate everyone on periods and the importance of having products readily available for when people get their period unexpectedly. To be inclusive to all menstruators, regardless of gender, Aunt Flow refers to “feminine hygiene products” as “period products.” 

Claire’s ultimate goal in life is for any menstruator to walk into any bathroom and never need to worry if they start their period, because Aunt Flow period products are freely available!

Claire’s story has been featured in TeenVogue, Forbes, and she starred in TLC’s Girl Starter Season 1. When she is not jamming out to Macklemore, she is teaching Zumba classes. Claire speaks regularly surrounding her advocacy work, starting a social enterprise and journey as a female founder. For more information, please visit www.clairecoder.com or www.goauntflow.com.

Registration for this event has closed.

About Payal Agrawal Divakaran

Payal is a Partner at .406 Ventures, where she co-leads the digital health investing practice. .406 Ventures is a Boston-based venture capital firm with $1.4B under management. Since its founding in 2005, .406 Ventures has never wavered from its strategy of investing in early-stage enterprise-focused startups in digital health, cybersecurity, and data & cloud.  Every member of the firm has deep operating or investing experience in these segments.

.406’s world-class founders and digital health companies are transforming healthcare technology and care delivery.  Payal’s portfolio includes AristaMD, Better Life Partners, Diana Health, Equip, Heartbeat Health, Laudio, Nomad Health, Redox, Wayspring, WelbeHealth, and Wellist. 

Payal joined .406 after her time at Harvard Business School, where she co-founded a company called SpotRocket to help students discover high potential startups to work for. Prior to her entrepreneurial stint and also while in business school, Payal spent time in Corporate Development at Eventbrite.

Prior to HBS, Payal was an Associate at Spectrum Equity, a technology growth equity investor in Boston. She sourced and executed on deals in the software, information services, data/analytics, security, and internet spaces. Payal started her career pursuing technology investment banking at J.P. Morgan in NYC.

Payal received her MBA, with Distinction, from Harvard Business School and her BS in Electrical Engineering and minor in Management from MIT. She is a Boston native and Boston sports fan, and she and her husband, who is a physician at Brigham and Women’s Hospital, and two kids live in Brookline.

About Kathryn Taylor Reddy

Kathryn is a Principal at .406 Ventures, a Boston-based venture capital firm with $1.4B under management that invests in early-stage enterprise-focused startups in digital health, cybersecurity, and data & cloud. Kathryn joined .406 in 2021 and focuses on early-stage companies that offer systems, technologies, and services that support and improve clinical delivery. Her .406 portfolio includes Diana Health, On Belay, InStride, Lynx, ClosedLoop, Cortica, and Tausight.

Prior to joining .406, Kathryn was a Vice President at BPEA, where she executed direct investments for BPEA’s Strategic Healthcare fund, a $352M fund that invests in healthcare companies on behalf of Taft-Hartley plans and other institutional investors. As part of her role at BPEA, she worked closely with Taft-Hartley leaders to understand their healthcare challenges and sourced investments to address their needs. Prior to BPEA, she invested in healthcare technology and life sciences startups at Excel Venture Management. Kathryn also has experience working with large provider systems, health plans, and pharmaceutical companies. She worked as a project manager in corporate strategy at the Advisory Board and as an advisor to the Chief Medical Officer at Boston Medical Center’s HealthNet plan. Kathryn started her career in consulting at Putnam Associates, where she worked with top 20 pharmaceutical companies on product and portfolio strategies.

Kathryn is originally from Houston, TX. In her spare time, she enjoys exploring the Boston area with her husband and 1.5-year old son and traveling back home to Texas. She received a BA in quantitative economics and international relations from Tufts University and an MBA from Harvard Business School.

Registration for this event has closed.

About Ayah Hamdan

Ayah Hamdan was born and raised in the Bay Area, having a front row seat to Silicon Valley’s tech and innovation growth. She holds a Bachelor’s degree in Public Health from UC Berkeley and a Master’s in Epidemiology from the Harvard T.H. Chan School of Public Health. Ayah has managed to blend her background in academia and quantitative health science with her interests in early stage technologies. While at Harvard Ayah launched her own startup, Fatima Connect which was a consulting and implementation service focused on bridging digital health solutions to refugee women users. Ayah also previously served in a leadership role at Carbon Health, primarily supporting their COVID-19 response initiatives. Currently, she works in VC & Corporate Innovation at Plug and Play ventures, driving their early stage digital health investments and supporting needs of corporate clients such as Roche, Bayer, Eli Lilly, Pfizer, Anthem, etc. Outside of her role at Plug and Play, she helps out at her family’s brunch restaurant in San Francisco.

Registration for this event has closed.

About Sarah Moug

Sarah is the Product Manager at Eli Health, where she connects the dots between their users, the development of the product, the regulatory strategy, and the long-term product vision. Sarah joined Eli as an intern while studying her Master's of Public Health in Health Management at the Harvard T. H. Chan School of Public Health, where her studies focused on the intersection of equity in Women and Gender Health and entrepreneurship. Prior to her MPH, Sarah worked as a management consultant at Accenture where she specialized in organizational change management, leadership, and culture. Sarah holds a Bachelor of Commerce in Business Technology Management from the University of British Columbia.

Registration for this event has closed.

About Alison Greenberg

Alison Greenberg is CEO and Co-Founder at Ruth Health, a perinatal telehealth hub and comprehensive care platform built for women by women. Prior to co-founding Ruth Health, Alison worked as an independent consultant in branding with companies such as—CVS Health, Summit Health/City MD, Stryker, Verizon, McDonald's, and more. Alison previously co-founded aflow, a conversational AI studio and is also the co-inventor of the Dioptra, a patent-pending gynecological and obstetric medical device. Alison received her Bachelor of Arts in Anthropology from Yale University. In 2019, she founded the New York City chapter of Women in Voice, a professional alliance of 3,000+ women/allies in voice tech and conversational AI with chapters in San Francisco, London, and Madrid. She is also on the NY Programming Board of StartOut, a non-profit driving economic empowerment of LGBTQ+ entrepreneurs.

Registration for this event has closed. Although a recording is not available for this event, a recap is available on our blog.

About Jill Angelo

Jill is the founder and CEO of Gennev whose mission is to improve the standard of healthcare for women in their post-reproductive years. Jill has 20 years’ experience in the tech industry, primarily at Microsoft in executive roles such as Chief of Staff to the Chief Marketing Officer, Director of Global Media, and Product Management for Emerging Markets. Jill is also a member of the Board of Directors for Special Olympics of Washington. Named as one of Inc. Magazine’s 2020 Top 100 Female Founders, Jill is a driving force for bringing effective health solutions to women in the most vibrant years of their lives.

Registration for this event has closed. A recording of this event is available here.

About Jennifer Hintzsche

Dr. Jenn Hintzsche is on a mission to market the first FDA-cleared over-the-counter assisted reproduction kit to provide hope for millions struggling to get pregnant. Dr. Jenn holds a Ph.D. in bioinformatics and has authored 24+ peer-reviewed scientific articles. Dr. Jenn, after getting married in 2016, struggled to conceive for a year before being diagnosed with unexplained infertility in 2017.  Fertility specialists told her that expensive fertility options were her only chance at becoming a mother.  Instead, Dr. Jenn took her fertility into her own hands and started digging into the scientific literature.  After 16 months, Hintzsche and her husband Ryan, a mechanical engineer, invented The PherDal Kit.  They used their now-patented medical device to conceive their daughter in just the second month of use.

Knowing she could help others struggling with infertility, Dr. Jenn started PherDal (pronounced "fertile" but spelled with a Ph.D.) to help others have an affordable and safe fertility option.  PherDal’s 200 proof-of-concept kits sold out in 90 days, with 30 reported pregnancies.  In 2022 PherDal crowdfunded over $630K to pay for FDA clearance testing and was a top 5 finalist for healthcare at the 2023 SXSW Pitch competition, and Dr. Jenn was a featured innovator in LSI’s Emerging MedTech Conference in 2023. Dr. Jenn is leading her team of medical, legal, and health tech experts to bring the first and only sterile, FDA-cleared, over-the-counter assisted reproduction kit to the market in 2023.

Registration for this event has closed. Although a recording is not available for this event, you can hear more from Candace via the LEK Insight Exchange podcast here.

About Candace Nagaraja

Candace is a Senior Engagement Manager and the US Women’s Health Lead at LEK Consulting, where she is leading development of the Women’s Health Vertical and specializes in marketing / commercial strategy across the Healthcare and Women’s Health & Femtech space (including provider services, digital health, and consumer/Medtech products). She also sits on the board of HerHealthEQ, an organization coordinating the supply of women’s health equipment to underserved geographies globally.

Candace has nearly 10 years of experience in go to market and commercialization strategy, both on the consulting side in her experience with LEK Consulting and from an industry POV in her experience as a Senior Instock Manager at Amazon. Candace has an AB from the University of Chicago College in Economics, and an MBA from the University of Chicago Booth.